A Study of Experimental Medication BMS-986036 Given to Healthy Participants

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Healthy participant, as determined by no clinically significant deviations from normal in medical history, physical examination, ECGs, and clinical laboratory determinations * BMI of 18 to ≤ 40 kg/m2 Exclusion Criteria: * Presence of any factors that would predispose the participant to infection (eg, extensive periodontal disease that warrants surgical or medical treatment, unhealed open wounds) * Any bone trauma (fracture) or bone surgery (i.e. hardware placement, joint replacement, bone grafting, or amputation) within 3 months of study drug administration * Known or suspected autoimmune disorder, excluding vitiligo * Any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status * Any significant acute or chronic medical illness * Current or recent (within 3 months of study drug administration) gastrointestinal disease * Any major surgery within 6 weeks of study drug administration * History of diabetes mellitus Other protocol defined inclusion/exclusion criteria could apply